Transaction · 0001104659-26-114081

Kaiser Peter

Kaiser Peter, CDO, reported an open-market or private sale at OCULAR THERAPEUTIX, INC involving 9990.000000 shares for an estimated $70429.50. Reported holdings after the transaction were 254388.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCDO
OCULOCULAR THERAPEUTIX, INC
Filing timeOct 06
Trade dateOct 02, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded3.78%Shares sold ÷ (holdings after + shares sold). Estimated position before: 264,378 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$7.29
Pre-filing
1mo ago +49.5%1w ago +32.4%1d ago +0.0%
Returns since
7d30d90d180d1y

OCUL price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
OCUL since 2026-10-06Filed 2 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001104659-26-114081
Common Stock
Transaction date
Oct 02, 2026
Filed Oct 06, 2026, 08:44 PM · 4d delay
Shares
9.99k sh
$7.05 per share
Estimated value
-$70.4k
Computed from shares × price
Holdings after
254k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership
+6score
Filing-only score

+6

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Development Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the…

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9900 to $7.1954, inclusive. The reporting person undertakes to pro…

Original filing · 0001104659-26-114081
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

OCUL